QuidelOrtho PE Ratio 2010-2023 | QDEL
Current and historical p/e ratio for QuidelOrtho (QDEL) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. QuidelOrtho PE ratio as of April 17, 2024 is 9.78.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| QuidelOrtho PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-17 | 38.71 | 0.00 | |
| 2023-12-31 | 73.70 | $-0.16 | 0.00 |
| 2023-09-30 | 73.04 | $0.19 | 384.42 |
| 2023-06-30 | 82.86 | $0.66 | 125.55 |
| 2023-03-31 | 89.09 | $1.82 | 48.95 |
| 2022-12-31 | 85.67 | $12.40 | 6.91 |
| 2022-09-30 | 71.48 | $18.80 | 3.80 |
| 2022-06-30 | 97.18 | $23.60 | 4.12 |
| 2022-03-31 | 112.46 | $23.69 | 4.75 |
| 2021-12-31 | 134.99 | $16.47 | 8.20 |
| 2021-09-30 | 141.15 | $20.40 | 6.92 |
| 2021-06-30 | 128.12 | $20.65 | 6.20 |
| 2021-03-31 | 127.93 | $21.75 | 5.88 |
| 2020-12-31 | 179.65 | $18.59 | 9.66 |
| 2020-09-30 | 219.38 | $8.52 | 25.75 |
| 2020-06-30 | 223.74 | $3.57 | 62.67 |
| 2020-03-31 | 97.81 | $2.05 | 47.71 |
| 2019-12-31 | 75.03 | $1.72 | 43.62 |
| 2019-09-30 | 61.35 | $1.79 | 34.27 |
| 2019-06-30 | 59.32 | $1.68 | 35.31 |
| 2019-03-31 | 65.47 | $1.57 | 41.70 |
| 2018-12-31 | 48.82 | $1.83 | 26.68 |
| 2018-09-30 | 65.17 | $0.90 | 72.41 |
| 2018-06-30 | 66.50 | $0.47 | 141.49 |
| 2018-03-31 | 51.81 | $0.20 | 259.05 |
| 2017-12-31 | 43.35 | $-0.24 | 0.00 |
| 2017-09-30 | 43.86 | $-0.15 | 0.00 |
| 2017-06-30 | 27.14 | $-0.01 | 0.00 |
| 2017-03-31 | 22.64 | $0.10 | 226.40 |
| 2016-12-31 | 21.42 | $-0.43 | 0.00 |
| 2016-09-30 | 22.09 | $-0.38 | 0.00 |
| 2016-06-30 | 17.86 | $-0.38 | 0.00 |
| 2016-03-31 | 17.26 | $-0.40 | 0.00 |
| 2015-12-31 | 21.20 | $-0.18 | 0.00 |
| 2015-09-30 | 18.88 | $0.03 | 629.33 |
| 2015-06-30 | 22.95 | $-0.12 | 0.00 |
| 2015-03-31 | 26.98 | $-0.06 | 0.00 |
| 2014-12-31 | 28.92 | $-0.21 | 0.00 |
| 2014-09-30 | 26.87 | $-0.38 | 0.00 |
| 2014-06-30 | 22.11 | $-0.34 | 0.00 |
| 2014-03-31 | 27.30 | $-0.19 | 0.00 |
| 2013-12-31 | 30.89 | $0.21 | 147.10 |
| 2013-09-30 | 28.40 | $0.44 | 64.55 |
| 2013-06-30 | 25.53 | $0.55 | 46.42 |
| 2013-03-31 | 23.75 | $0.50 | 47.50 |
| 2012-12-31 | 18.67 | $0.14 | 133.36 |
| 2012-09-30 | 18.93 | $-0.09 | 0.00 |
| 2012-06-30 | 15.68 | $-0.10 | 0.00 |
| 2012-03-31 | 18.37 | $-0.11 | 0.00 |
| 2011-12-31 | 15.13 | $0.24 | 63.04 |
| 2011-09-30 | 16.37 | $0.20 | 81.85 |
| 2011-06-30 | 15.15 | $0.02 | 757.50 |
| 2011-03-31 | 11.96 | $0.04 | 299.00 |
| 2010-12-31 | 14.45 | $-0.40 | 0.00 |
| 2010-09-30 | 10.99 | $0.28 | 39.25 |
| 2010-06-30 | 12.69 | $0.99 | 12.82 |
| 2010-03-31 | 14.54 | $1.10 | 13.22 |
| 2009-12-31 | 13.78 | $1.10 | 12.53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.695B | $2.998B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $189.499B | 24.60 |
| Stryker (SYK) | United States | $128.469B | 31.85 |
| Medtronic (MDT) | Ireland | $105.230B | 14.90 |
| Boston Scientific (BSX) | United States | $99.939B | 33.23 |
| EssilorLuxottica (ESLOY) | France | $98.203B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.924B | 0.00 |
| Haleon (HLN) | United Kingdom | $36.986B | 28.93 |
| ResMed (RMD) | United States | $27.191B | 27.18 |
| Terumo (TRUMY) | Japan | $25.327B | 35.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.081B | 16.15 |
| Baxter (BAX) | United States | $20.095B | 14.66 |
| Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
| Insulet (PODD) | United States | $12.094B | 63.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.404B | 0.00 |
| Demant (WILYY) | Denmark | $10.151B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.349B | 24.87 |
| BellRing Brands (BRBR) | United States | $7.231B | 38.88 |
| Haemonetics (HAE) | United States | $4.275B | 21.86 |
| Lantheus Holdings (LNTH) | United States | $4.232B | 10.93 |
| Perrigo (PRGO) | Ireland | $4.060B | 11.61 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Envista Holdings (NVST) | United States | $3.399B | 12.93 |
| Prestige Consumer Healthcare (PBH) | United States | $3.379B | 15.98 |
| Neogen (NEOG) | United States | $2.634B | 25.33 |
| Green Thumb Industries (GTBIF) | United States | $2.613B | 82.80 |
| ICU Medical (ICUI) | United States | $2.347B | 17.51 |
| TG Therapeutics (TGTX) | United States | $2.162B | 700.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.046B | 0.00 |
| Owens & Minor (OMI) | United States | $1.903B | 18.27 |
| Verano Holdings (VRNOF) | United States | $1.686B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.618B | 0.00 |
| InMode (INMD) | Israel | $1.480B | 7.66 |
| National Vision Holdings (EYE) | United States | $1.479B | 46.05 |
| LeMaitre Vascular (LMAT) | United States | $1.430B | 47.50 |
| AdaptHealth (AHCO) | United States | $1.277B | 9.61 |
| Warby Parker (WRBY) | United States | $1.241B | 0.00 |
| AtriCure (ATRC) | United States | $1.117B | 0.00 |
| MacroGenics (MGNX) | United States | $1.044B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.725B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
| Evolus (EOLS) | United States | $0.698B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.698B | 15.07 |
| Jin Medical (ZJYL) | China | $0.673B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.610B | 0.00 |
| Quanterix (QTRX) | United States | $0.610B | 0.00 |
| Valneva SE (VALN) | France | $0.556B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.526B | 11.40 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| PetIQ (PETQ) | United States | $0.477B | 17.80 |
| ZimVie (ZIMV) | United States | $0.427B | 26.15 |
| Biote (BTMD) | United States | $0.426B | 4.05 |
| OraSure Technologies (OSUR) | United States | $0.399B | 6.61 |
| Zynex (ZYXI) | United States | $0.391B | 45.00 |
| Surmodics (SRDX) | United States | $0.379B | 40.92 |
| Aurora Cannabis (ACB) | Canada | $0.322B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.320B | 31.77 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.253B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 14.91 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.195B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.187B | 0.00 |
| Veru (VERU) | United States | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.132B | 21.19 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.125B | 62.70 |
| Allurion Technologies (ALUR) | United States | $0.113B | 0.00 |
| InterCure (INCR) | Israel | $0.108B | 18.23 |
| Cellectar Biosciences (CLRB) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.106B | 9.12 |
| Safety Shot (SHOT) | United States | $0.102B | 0.00 |
| MariMed (MRMD) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Brainsway (BWAY) | Israel | $0.085B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.97 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.91 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.020B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.36 |
| ProSomnus (OSA) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |